Research Tracker›Biomarker Atlas›Rheumatoid Arthritis›Anti-CCP Antibodies

Anti-CCP Antibodies in Rheumatoid Arthritis

Anti-CCP Antibodies is a immune marker reported as elevated in Rheumatoid Arthritis when patients are compared with the reference group of the cited comparison (RA vs healthy (specific marker)). The source does not tie this marker to a specific symptom cluster, so it is best read as a biological signal rather than a symptom predictor. The finding is drawn from Matuszewska et al. 2016; it describes group-level differences, not a threshold that classifies an individual.

↑ ElevatedImmune

Summary

Direction in Rheumatoid Arthritis↑ Elevated — higher than in the comparison group
CategoryImmune
Compared againstRA vs healthy (specific marker)
SourceMatuszewska et al. 2016 — doi:10.5604/17322693.1198270
Condition atlasRheumatoid Arthritis Biomarker Atlas

Related Immune markers in Rheumatoid Arthritis

Full list: Rheumatoid Arthritis Biomarker Atlas.

Frequently asked questions

Is Anti-CCP Antibodies high or low in Rheumatoid Arthritis?

Elevated. Studies summarised in the OSMF atlas report higher Anti-CCP Antibodies in Rheumatoid Arthritis than in the reference group of the cited comparison (RA vs healthy (specific marker)). Source: Matuszewska et al. 2016.

Which test measures Anti-CCP Antibodies?

The atlas record does not list a standardised clinical test code (LOINC) for Anti-CCP Antibodies, which usually means it was measured with research assays or study-specific protocols rather than a routine clinical panel. Check the cited source for the exact method.

Is one abnormal Anti-CCP Antibodies result diagnostic of Rheumatoid Arthritis?

No. No single biomarker is diagnostic of Rheumatoid Arthritis. Anti-CCP Antibodies findings come from group comparisons, overlap considerably between patients and controls, and vary with study design, timing and comparison group. A result should be interpreted by a clinician alongside symptoms, history and other tests.

Cite this page

Open Source Medicine Foundation. (2026). Anti-CCP Antibodies in Rheumatoid Arthritis: direction, evidence and what it means. OSMF Research Tracker. Retrieved October 7, 2026, from https://research.opensourcemed.info/biomarkers/rheumatoid-arthritis/anti-ccp-antibodies.html
Get OSMF research updates. New biomarker, trial and treatment evidence summaries by email.
Subscribe on Substack

Last reviewed: 2026-07-03 · Page generated from rheumatoid-arthritis.json · Browse: Rheumatoid Arthritis atlas · Biomarker Index · All marker pages

Disclaimer: This page is an educational synthesis of published, peer-reviewed research and is not medical advice. Biomarker findings vary across studies with case definitions, comparison groups, timing and assay methods. Direction of change reflects the predominant finding in the cited source and does not establish a diagnostic threshold. Discuss any test result with a qualified clinician.